Arthritis is a debilitating condition that affects senior dogs, causing pain and discomfort that can greatly diminish their quality of life. Fortunately, advancements in veterinary medicine have introduced promising treatments like Librela, a novel medication designed to alleviate arthritis symptoms in dogs.
“In the field of pet hospice and euthanasia, quality of life and the ability to manage pain are key factors that weigh into difficult decisions. Many senior dogs can enjoy an improved quality of life and an extension of their sunset years through treatment with this game-changing class of drugs,” said Dr. Laurie Brush, founder of Heaven at Home Pet Hospice.
Librela is part of a new class of drugs known as disease-modifying osteoarthritis drugs (DMOADs) that target the underlying causes of arthritis, rather than merely masking symptoms. The active ingredient in Librela is known as “arti-antagonist,” which works by inhibiting the production of inflammatory molecules and promoting joint health.
Ways Librela Can Help
- Pain Reduction: One of the primary benefits of Librela is its ability to reduce pain associated with arthritis in dogs. A study published in the Journal of Veterinary Medicine found that dogs receiving Librela experienced a significant decrease in pain scores compared to a control group.
- Improved Joint Function: Arthritis often leads to decreased mobility and joint stiffness in dogs. Librela has been shown to improve joint movement and agility, allowing them to engage in more physical activities.
- Cartilage Protection: Librela helps protect and preserve cartilage in arthritic joints, which is crucial for long-term joint health and mobility.
- Reduced Inflammation: Inflammation is a key driver of arthritis pain. Librela works to decrease inflammation in the joints, thus reducing pain and swelling.
- Minimal Side Effects: Another significant benefit of Librela is its relatively low incidence of side effects compared to some traditional arthritis medications. Research has reported that adverse reactions to Librela are rare and generally mild.
Librela represents a promising advancement in the reduction of pain, improved joint function, preserved cartilage, and reduced inflammation. If your dog is suffering from arthritis, consult with your veterinarian to discuss the suitability of Librela as part of a comprehensive treatment plan. It may put a new spring in the step of your beloved companion, and extend your time together.